BioSpace News Archive

BioQuest Corp, (OTC:BQST), a FULLY Reporting Company and provider of high end CBD products to the retail, direct and internet markets, it is pleased to announce the Company’s plans to up list to the OTCQB market within the next few weeks. The application process will not guarantee acceptance of Company’s application by OTCMARKETS from the PINKS to OTCQB.. BioQuest, Corporation - markets, packages and distributes an assortment of Hemp-CBD based

Explora BioLabs, the nation’s largest provider of pre-clinical vivarium, husbandry, and research space, will launch its first East Coast facility here in mid-2021.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez , the company’s president and chief executive officer, is scheduled to present a company overview at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Thursday, January 14, 2021 at 10:00 a.m. Eastern Time . To access the li

The Supervisory Board of Synthon BV, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines for patients around the world, is pleased to announce that Anish Mehta is appointed as Chief Executive Officer and member of the Board of Directors, effective immediately.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present at the H.C. Wainwright Virtual BioConnect Conference being held from January 11-14, 2021. A webcast of the on-demand presentation will be available on the investor section of the X4 Pharmaceuticals website at www.x4pharma.com and at

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® technology platform, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present virtually at the 39 th Annual J.P. Morgan Healthcare Conference on January 14 th at 11:40 a.m. ET. CytomX Thera

Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will present at the virtual H.C. Wainwright BioConnect 2021 Conference being held January 11-14, 2021. The Company’s presentation will be available on demand starting Monday, January 11

ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited sales results for the year ended December 31, 2020. Beginning with the first quarter of 2020, the Company has been providing a preliminary look at the top

Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial results for the first quarter of fiscal 2021.

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021 at 5:20 p.m. ET. A live webcast of the presentation will be available on t